LAUREN WILSON: Open Payments
NPI 1043701741 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: REXULTI, TRINTELLIX, FANAPT, CAPLYTA, AUSTEDO XR, Sunosi.
Industry payments across FL — which companies pay providers there.
